These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24244046)

  • 1. Human Serotonin 5-HT
    Rdova-Sintjago TC; Villa N; Canal C; Booth R
    Int J Quantum Chem; 2012 Jan; 112(1):. PubMed ID: 24244046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation.
    Canal CE; Cordova-Sintjago TC; Villa NY; Fang LJ; Booth RG
    Eur J Pharmacol; 2011 Dec; 673(1-3):1-12. PubMed ID: 22020288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands.
    Canal CE; Cordova-Sintjago T; Liu Y; Kim MS; Morgan D; Booth RG
    J Pharmacol Exp Ther; 2013 Dec; 347(3):705-16. PubMed ID: 24080681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Determinants for Ligand Binding at Serotonin 5-HT
    Córdova-Sintjago T; Sakhuja R; Kondabolu K; Canal CE; Booth RG
    Int J Quantum Chem; 2012 Dec; 112(24):3807-3814. PubMed ID: 23913978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity.
    Booth RG; Fang L; Huang Y; Wilczynski A; Sivendran S
    Eur J Pharmacol; 2009 Aug; 615(1-3):1-9. PubMed ID: 19397907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatic interactions impact ligand binding and function at serotonin 5-HT
    Córdova-Sintjago T; Villa N; Fang L; Booth RG
    Mol Phys; 2014 Jan; 112(3-4):398-407. PubMed ID: 24729635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis Analysis Reveals Distinct Amino Acids of the Human Serotonin 5-HT
    Liu Y; Canal CE; Cordova-Sintjago TC; Zhu W; Booth RG
    ACS Chem Neurosci; 2017 Jan; 8(1):28-39. PubMed ID: 27580242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of ligand binding at the human histamine H
    Cordova-Sintjago TC; Fang L; Bruysters M; Leurs R; Booth RG
    J Chem Pharm Res; 2012 Jun; 4(6):2937-2951. PubMed ID: 25013351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of 5-HT
    Casey AB; Mukherjee M; McGlynn RP; Cui M; Kohut SJ; Booth RG
    Br J Pharmacol; 2022 Jun; 179(11):2610-2630. PubMed ID: 34837227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors.
    Sakhuja R; Kondabolu K; Córdova-Sintjago T; Travers S; Vincek AS; Kim MS; Abboud KA; Fang L; Sun Z; Canal CE; Booth RG
    Bioorg Med Chem; 2015 Apr; 23(7):1588-600. PubMed ID: 25703249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis.
    Impellizzeri AA; Pappalardo M; Basile L; Manfra O; Andressen KW; Krobert KA; Messina A; Levy FO; Guccione S
    Front Behav Neurosci; 2015; 9():92. PubMed ID: 26005408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
    Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.
    Canal CE; Booth RG; Morgan D
    Neuropharmacology; 2013 Jul; 70():112-21. PubMed ID: 23353901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short history of the 5-HT
    Palacios JM; Pazos A; Hoyer D
    Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
    Herrick-Davis K; Grinde E; Harrigan TJ; Mazurkiewicz JE
    J Biol Chem; 2005 Dec; 280(48):40144-51. PubMed ID: 16195233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
    J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.